PMDIY (Pro Medicus) 5-Year Yield-on-Cost %: 1.31 (As of Jul. 11, 2026) — Near Median


PMDIY Pro Medicus Ltd PMDIY
77 GF Score
Price $30.00
GF Value $39.87
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pro Medicus 5-Year Yield-on-Cost %?

Pro Medicus PMDIY +3.45% 77 5-Year Yield-on-Cost % is 1.31 as of Jul. 11, 2026, which is 6% below its 10-year median of 1.40. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $39.87 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 280 Healthcare Providers & Services companies, Pro Medicus ranks worse than 74.64% on this metric.

Pro Medicus's yield on cost for the quarter that ended in Dec. 2025 was 1.31.


The historical rank and industry rank for Pro Medicus's 5-Year Yield-on-Cost % or its related term are showing as below:

PMDIY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.56   Med: 1.4   Max: 2.99
Current: 1.31


During the past 13 years, Pro Medicus's highest Yield on Cost was 2.99. The lowest was 0.56. And the median was 1.40.


PMDIY's 5-Year Yield-on-Cost % is ranked worse than
74.64% of 280 companies
in the Healthcare Providers & Services industry
Industry Median: 2.945 vs PMDIY: 1.31

Pro Medicus  (OTCPK:PMDIY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Pro Medicus 5-Year Yield-on-Cost % Related Terms


PMDIY vs VEEV, BTSG, TEM: 5-Year Yield-on-Cost % Comparison

For the Health Information Services subindustry, Pro Medicus's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Pro Medicus's 5-Year Yield-on-Cost % falls into.


PMDIY
77GF Score
Pro Medicus Ltd PMDIY
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pro Medicus 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Pro Medicus is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 1.31 mean?
Pro Medicus (PMDIY) has a 5-Year Yield-on-Cost % of 1.31 as of Jul. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Pro Medicus and its competitors. This is near median its historical median of 1.40. Over the past decade, Pro Medicus' 5-Year Yield-on-Cost % has ranged from 0.56 to 2.99. According to the industry distribution chart, Pro Medicus ranks #209 out of 280 companies in the Healthcare Providers & Services industry, placing it in the top 74.6%.
Is Pro Medicus' 5-Year Yield-on-Cost % too high?
Pro Medicus' current 5-Year Yield-on-Cost % of 1.31 is near median its 10-year median of 1.40. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 2.99. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.95. Pro Medicus' value of 1.31 is 55.5% below this industry median. Based on the distribution chart, Pro Medicus ranks #209 out of 280 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' 5-Year Yield-on-Cost % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #209 out of 280 companies for 5-Year Yield-on-Cost %. This places Pro Medicus in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.95. Pro Medicus' value of 1.31 is 55.5% below this benchmark. Historically, Pro Medicus' own 5-Year Yield-on-Cost % has ranged from 0.56 to 2.99 over the past decade. While the company's 10-year median is 1.40 vs. the industry median of 2.95, Pro Medicus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.95, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current 5-Year Yield-on-Cost % of 1.31 is 55.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current 5-Year Yield-on-Cost % is 1.31, which is near median its own 10-year median of 1.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.87, compared to a current price of $30.00 — trading 24.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.31, which is near median its 10-year median of 1.40 and 55.5% below the Healthcare Providers & Services industry median of 2.95. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current 5-Year Yield-on-Cost % is 1.31 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro Medicus (PMDIY) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of $30.00 is trading 24.8% below its estimated GF Value™ of $39.87. GuruFocus considers Pro Medicus to be Modestly Undervalued.

Key valuation signals for PMDIY:

  • 5-Year Yield-on-Cost %: 1.31 (near median its 10-year median of 1.40)
  • GF Value™: $39.87 vs. price of $30.00 (24.8% below fair value)
  • GF Score™: 77/100 with 1 warning sign
  • Industry Position: 55.5% below the Healthcare Providers & Services median (#209 of 280)

No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score

Get the complete analysis for PMDIY

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.00
Price
$39.87
GF Value